These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29537443)

  • 1. Clinical Insights About Onychomycosis and Its Treatment: A Consensus.
    Hanna S; Andriessen A; Beecker J; Gilbert M; Goldstein E; Kalia S; King A; Kraft J; Lynde C; Singh D; Turchin I; Zip C
    J Drugs Dermatol; 2018 Mar; 17(3):253-262. PubMed ID: 29537443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toenail Onychomycosis-A Canadian Approach With a New Transungual Treatment: Development of a Clinical Pathway.
    Gupta AK; Sibbald RG; Andriessen A; Belley R; Boroditsky A; Botros M; Chelin R; Gulliver W; Keast D; Raman M
    J Cutan Med Surg; 2015; 19(5):440-9. PubMed ID: 25857439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US.
    Lipner SR; Joseph WS; Vlahovic TC; Scher RK; Rich P; Ghannoum M; Daniel CR; Elewski B
    J Drugs Dermatol; 2021 Oct; 20(10):1076-1084. PubMed ID: 34636509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
    Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
    J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
    Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
    PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efinaconazole and Tavaborole.
    Poulakos M; Grace Y; Machin JD; Dorval E
    J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel investigational therapies for onychomycosis: an update.
    Gupta AK; Studholme C
    Expert Opin Investig Drugs; 2016; 25(3):297-305. PubMed ID: 26765142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onychomycosis in children. A review.
    Solís-Arias MP; García-Romero MT
    Int J Dermatol; 2017 Feb; 56(2):123-130. PubMed ID: 27612431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey among dermatologists: diagnostics of superficial fungal infections - what is used and what is needed to initiate therapy and assess efficacy?
    Saunte DML; Piraccini BM; Sergeev AY; Prohić A; Sigurgeirsson B; Rodríguez-Cerdeira C; Szepietowski JC; Faergemann J; Arabatzis M; Pereiro M; Skerlev M; Lecerf P; Schmid-Grendelmeier P; Nenoff P; Nowicki RJ; Emtestam L; Hay RJ
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):421-427. PubMed ID: 30468532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.
    Bristow I; Baran R; Score M
    J Drugs Dermatol; 2016 Aug; 15(8):974-8. PubMed ID: 27537998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
    Eichenfield LF; Friedlander SF
    J Drugs Dermatol; 2017 Feb; 16(2):105-109. PubMed ID: 28300851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of nail mycoses].
    Büchner SA
    Ther Umsch; 1998 Aug; 55(8):503-8. PubMed ID: 9757817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Treatment of Onychomycosis and Clinically Meaningful Outcomes.
    Gupta AK; Korotzer A
    J Drugs Dermatol; 2016 Oct; 15(10):1260-1266. PubMed ID: 27741345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal Drug Use for Onychomycosis.
    Thomas J; Peterson GM; Christenson JK; Kosari S; Baby KE
    Am J Ther; 2019; 26(3):e388-e396. PubMed ID: 31082864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis: Rapid Evidence Review.
    Frazier WT; Santiago-Delgado ZM; Stupka KC
    Am Fam Physician; 2021 Oct; 104(4):359-367. PubMed ID: 34652111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.